Lv2
108 积分 2025-12-31 加入
Efruxifermin combined with a GLP-1 receptor agonist reduces liver fat in NASH
6个月前
已完结
Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial
6个月前
已完结
Safety and efficacy of once-weekly efruxifermin versus placebo in metabolic dysfunction-associated steatohepatitis (HARMONY): 96-week results from a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
6个月前
已完结
A phase 1/2A Trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohnʼs disease
6个月前
已关闭
Hepatic‐Targeted Liposomes‐Ginger‐Derived Exosomes Hybrid Nanocarrier for Synergistic Alleviation of Obesity‐Induced Nonalcoholic Steatohepatitis
6个月前
已完结
Docking and Molecular Dynamics Simulations of Peroxisome Proliferator Activated Receptors Interacting with Pan Agonist Sodelglitazar
6个月前
已完结
Tripterygium wilfordii Hook. f. versus azathioprine for prevention of postoperative recurrence in patients with Crohn's disease: A randomized clinical trial
6个月前
已完结
A Calibration Method for the Resolution of 2D TPP Laser Direct Writing
皖公网安备34019202002308
